Jefferies Downgrades Collegium Pharmaceutical (COLL) to Hold, 'Well-Played Cap Deployment Strategy Yields Windfall for Investors'
Tweet Send to a Friend
(Updated - January 4, 2024 5:03 AM EST)
Jefferies analyst Glen Santangelo downgraded Collegium Pharmaceutical (NASDAQ: COLL) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Glen Santangelo downgraded Collegium Pharmaceutical (NASDAQ: COLL) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
